ASTELLAS INNOVATION MANAGEMENT AIM Trademark

Trademark Overview

On Friday, September 6, 2013, a trademark application was filed for ASTELLAS INNOVATION MANAGEMENT AIM with the United States Patent and Trademark Office. The USPTO has given the ASTELLAS INNOVATION MANAGEMENT AIM trademark a serial number of 79139114. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, September 5, 2023. This trademark is owned by Astellas Pharma Inc.. The ASTELLAS INNOVATION MANAGEMENT AIM trademark is filed in the Insurance & Financial Services and Computer & Software Services & Scientific Services categories with the following description:

Providing grants for research

Testing, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals
astellas innovation management aim

General Information

Serial Number79139114
Word MarkASTELLAS INNOVATION MANAGEMENT AIM
Filing DateFriday, September 6, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, September 5, 2023
Registration Number4541322
Registration DateTuesday, June 3, 2014
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 18, 2014

Trademark Statements

Description of MarkThe mark consists of the wording "ASTELLAS INNOVATION MANAGEMENT AIM" with "ASTELLAS INNOVATION MANAGEMENT" appearing in the color gray and the term "AIM" appearing in the color red, with a red and gray stylized star appearing next to the term "ASTELLAS" and a horizontal line appearing below the star and the term "ASTELLAS".
Goods and ServicesProviding grants for research
Indication of Colors claimedThe color(s) red and gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"INNOVATION MANAGEMENT"
Goods and ServicesTesting, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Sunday, March 31, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, March 31, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, March 31, 2024DEATH OF INTERNATIONAL REGISTRATION
Saturday, June 25, 2022NEW REPRESENTATIVE AT IB RECEIVED
Sunday, April 17, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, March 10, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, March 10, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Friday, October 23, 2020NEW REPRESENTATIVE AT IB RECEIVED
Monday, June 3, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, November 8, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, October 23, 2014FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 23, 2014FINAL DISPOSITION PROCESSED
Wednesday, September 3, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 3, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, March 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 18, 2014PUBLISHED FOR OPPOSITION
Friday, March 14, 2014NOTIFICATION PROCESSED BY IB
Wednesday, February 26, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 26, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 12, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 11, 2014ASSIGNED TO LIE
Thursday, January 23, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 17, 2014REFUSAL PROCESSED BY IB
Tuesday, January 14, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 13, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 13, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 31, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 31, 2013REFUSAL PROCESSED BY MPU
Tuesday, December 24, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, December 23, 2013NON-FINAL ACTION WRITTEN
Wednesday, December 18, 2013ASSIGNED TO EXAMINER
Friday, December 6, 2013APPLICATION FILING RECEIPT MAILED
Monday, December 2, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 28, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

management innovation astellas research development pharmaceuticals providing inspection testing relating grants information